ABC | Volume 110, Nº6, June 2018

Original Article Soares et al Cardiovascular risk in an indigenous population Arq Bras Cardiol. 2018; 110(6):542-550 13. Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al; Sociedade Brasileira de Cardiologia. [V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis]. Arq Bras Cardiol. 2013;101(4 Suppl 1):1-20. 14. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals fromtheCenters forDiseaseControlandPreventionandtheAmericanHeart Association. Circulation. 2003;107(3):499-511. 15. Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994;21(1):55-67. 16. WorldHealthOrganization. (WHO). Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. part 1: diagnosis and classification of diabetes mellitus. Geneva; 1999. 17. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de hipertensão. Arq Bras Cardiol. 2010;95(1 supl. 1):1-51. 18. Oberman A, Kreisberg RA. Hypertrigliceridemia and coronary heart disease. J Clin Endocrinol Metab. 2000;85(6):2089-112. 19. Rocha AK, Bós AJ, Huttner E, Machado DC. Prevalence of metabolic syndrome in indigenous people over 40 years of age in Rio Grande do Sul, Brazil. Rev Panam Salud Publica. 2011;29(1):41-5. 20. Santos KM, Tsutsui ML, Galvão PP, Mazzucchetti L, Rodrigues D, Gimeno SG. Degree of physical activity and metabolic syndrome: a cross-sectional study among the Khisêdjê group in the Xingu Indigenous Park, Brazil. Cad Saude Publica. 2012; 28 (12):2327-38. 21. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med. 2006;259(5):493-519. 22. Lima LM, CarvalhoMG, Sousa MO. Apo B/apo A-I ratio and cardiovascular risk prediction. Arq Bras Cardiol. 2007;88(6):e187-90. 23. Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. Impact of obesity on cardiovascular disease. Endocrinol Metab Clin North Am. 2008;37(3):663-84. 24. Brasil. Ministério da Saúde – Fundação Nacional de Saúde (FUNASA). Inquérito nacional de saúde e nutrição dos povos indígenas. Relatório Final. Brasília; 2009. 25. Salvo VL, Rodrigues D, Baruzzi RG, Pagliaro H, Gimeno SG. Metabolic and anthropometric profile of Suyá. Xingu Indigenous Park, Central Brazil. Rev Bras Epidemiol. 2009;12(3):458-68. 26. Lourenço AE, Santos RV, Orellana JD, Coimbra CE Jr. Nutrition transition in Amazonia: obesity and socioeconomic change in the Suruí Indians from Brazil. Am J Hum Biol. 2008;20(5):564-71. 27. Welch JR, Ferreira AA, Santos RV, Gugelmin SA, Werneck G, Coimbra CE Jr. Nutrition transition, socioeconomic differentiation, and gender among adult Xavante Indians, Brazilian Amazon. Hum Ecol. 2009;37(1):13-26. 28. Arsenault BJ, Lemieux I, Despres JP, Wareham NJ, Kastelein JJ, Khaw KT, et al . The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ. 2010;182(13):1427-32. 29. Mendes MS, Melendez JG. Cintura hipertrigliceridêmica e sua associação com fatores de risco metabólicos [Dissertação]. Belo Horizonte: Universidade Federal de Minas Gerais; 2009. 30. Oliveira JL, Lopes LL, Pelúzio, MC, Hermsdorff HH. Hypertriglyceridemic waist phenotype and cardiometabolic risk in dyslipidemic subjects. Rev Bras Cardiol. 2014;27(6):395-402. 31. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation. 1979;59(1):8-13. 32. Stamler J, VaccaroO, Neaton JD, WentworthD. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434-44. 33. Malerbi D, Franco LJ.Multicenter study of the prevalence of diabetesmellitus and impaired glucose tolerance in the urban Brazilian population aged 30 to 69 yr. The BrazilianCooperativeGroup on the Study of Diabetes Prevalence. Diabetes Care. 1992;15(11):1509-16. 34. Oliveira GF, Oliveira TR, Rodrigues FF, Corrêa LF, Ikejiri AT, Casulari LA. Prevalence of diabetes mellitus and impaired glucose tolerance in indigenous people fromAldeia Jaguapiru, Brazil. Rev PanamSalud Publica. 2011;29(5):315-21. 35. Passos VM, Assis TD, Barreto SM. Hypertension in Brazil: estimates from population-based prevalence studies. Epidemiol Serv Saúde. 2006;15(1):35-45. 36. Brasil. Ministério da Saúde. VIGITEL Brasil 2013: Vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília; 2014. 37. Neel JV, Salzano FM, Junqueira PC, Ketter F, Maybury-Lewis D. Studies on the Xavante Indians of the Brazilian Mato Grosso. Am J Hum Genet 1964 Mar;16:52-140. 38. OliveiraMVG. Níveis tensionais e prevalência de hipertensão entre os Xavante, TerraIndígenaPimentelBarbosa,MatoGrosso[Dissertação].RiodeJaneiro:Escola NacionaldeSaúdePúblicaSergioArouca.FundaçãoOswaldoCruz;2011. 549